User Profile
/
Watchlists
/
Beat the Benchmark 2026 Portfolio - Possible list

Beat the Benchmark 2026 Portfolio - Possible list

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Clive_Thompson

206 followers128 views

Watching

Company	Price & Valuation	My FV & Narrative	Valuation	Growth	Analyst Target
2419 Dekon Food and Agriculture Group HK$46.8253.7% undervalued intrinsic discount 19.0%7D -29.4%3M HK$101.02author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$101.02 based on 10.0% annual revenue growth forecasts.
RHM Rheinmetall €1,050.6044.4% undervalued intrinsic discount 10.7%7D -33.1%3M AN €1.89kauthor fair value 15 Junauthor updated this narrative Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall
ALHC Alignment Healthcare US$24.013.7% undervalued intrinsic discount 10.7%7D 28.0%3M AN US$24.92author fair value 30 Mayauthor updated this narrative ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains
9911 Newborn Town HK$8.2041.3% undervalued intrinsic discount 8.6%7D -0.5%3M HK$13.97author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.
NIC Nicolet Bankshares US$168.823.1% undervalued intrinsic discount 8.0%7D 13.4%3M US$174.2author fair value 25 Julauthor updated this narrative Analysts are neutral with a Price Target of $174.20 based on 27.2% annual revenue growth forecasts.
MNSO MINISO Group Holding US$12.1840.2% undervalued intrinsic discount 7.3%7D -24.2%3M AN US$20.37author fair value 29 Junauthor updated this narrative Global Retail Expansion And Premium IP Will Unlock Opportunity
CCB Coastal Financial US$79.8424.9% undervalued intrinsic discount 6.6%7D 2.8%3M US$106.25author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.
CAMX Camurus SEK 577.0025.1% undervalued intrinsic discount 6.1%7D 19.3%3M AN SEK 770.13author fair value 29 Aprauthor updated this narrative Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery
ARGX argenx €793.608.7% undervalued intrinsic discount 6.0%7D 22.6%3M AN €869.07author fair value 30 Junauthor updated this narrative ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook
999 Xiaocaiyuan International Holding HK$6.9123.6% undervalued intrinsic discount 5.5%7D 1.6%3M HK$9.04author fair value 19 Decauthor updated this narrative Analysts are bullish with a Price Target of HK$9.04 based on 3.8% annual revenue growth forecasts.
MELI MercadoLibre US$1,742.1921.4% undervalued intrinsic discount 5.0%7D 1.6%3M AN US$2.22kauthor fair value 15 Junauthor updated this narrative Digital Retail And MercadoPago Adoption Will Fuel Future Markets
ONC BeOne Medicines US$290.7429.5% undervalued intrinsic discount 4.9%7D -6.5%3M AN US$412.35author fair value 24 Junauthor updated this narrative ONC: Pivotal Oncology Trial Data Will Drive Future Upside Momentum
BAER Julius Bär Gruppe CHF 71.843.6% overvalued intrinsic discount 4.9%7D 20.3%3M AN CHF 69.35author fair value 18 Junauthor updated this narrative Digital Transformation And Global Wealth Transfers Will Empower Private Banking
BDT Bird Construction CA$64.7374.9% overvalued intrinsic discount 4.6%7D 57.0%3M AN CA$37author fair value 28 Marauthor updated this narrative Defense And Data Center Backlog Will Support Stable Long Term Earnings Profile
FITB Fifth Third Bancorp US$57.491.2% undervalued intrinsic discount 4.6%7D 22.0%3M AN US$58.18author fair value 25 Junauthor updated this narrative Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts
8795 T&D Holdings JP¥4,904.008.9% overvalued intrinsic discount 4.6%7D 18.1%3M AN JP¥4.51kauthor fair value 02 Mayauthor updated this narrative Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins
HRMY Harmony Biosciences Holdings US$36.0023.9% undervalued intrinsic discount 4.5%7D 29.8%3M AN US$47.3author fair value 23 Febauthor updated this narrative Expanding Sleep And Rare Disease Markets Will Unlock Future Potential
MLYS Mineralys Therapeutics US$26.8947.1% undervalued intrinsic discount 4.3%7D -0.3%3M AN US$50.88author fair value 05 Marauthor updated this narrative Hypertension And Cardiorenal Catalysts Will Reshape Long Term Prospects For This Biotech
MRK Merck US$125.373.4% undervalued intrinsic discount 4.0%7D 3.7%3M AN US$129.74author fair value 01 Junauthor updated this narrative US Investments And New Product Launches Will Shape Future Markets
MONY MONY Group UK£1.9032.1% undervalued intrinsic discount 3.9%7D 26.2%3M AN UK£2.8author fair value 04 Junauthor updated this narrative Rising Middle Class And AI Integration Will Expand Markets
PNFP Pinnacle Financial Partners US$100.8213.7% undervalued intrinsic discount 3.9%7D 15.3%3M AN US$116.79author fair value 05 Junauthor updated this narrative PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside
RUSTA Rusta SEK 81.408.9% undervalued intrinsic discount 3.4%7D -13.3%3M AN SEK 89.33author fair value 22 Junauthor updated this narrative Upcoming Store Expansion And Supply Chain Investments Will Increase Future Market Reach
COLB Columbia Banking System US$32.510.9% overvalued intrinsic discount 3.1%7D 17.2%3M AN US$32.23author fair value 24 Junauthor updated this narrative COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance
HBAN Huntington Bancshares US$18.1179.1% overvalued intrinsic discount 3.0%7D 14.7%3M MS US$10.11author fair value 27 Sepauthor updated this narrative Overvalued HBAN
ADS adidas €183.208.3% undervalued intrinsic discount 3.0%7D 35.8%3M AN €199.71author fair value 18 Junauthor updated this narrative ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny
AU AngloGold Ashanti US$80.8934.4% undervalued intrinsic discount 2.9%7D -20.1%3M AN US$123.29author fair value 28 Mayauthor updated this narrative AU: Strengthening Margins And Revenue Will Drive Upward Momentum In Coming Years
SFNC Simmons First National US$23.221.5% undervalued intrinsic discount 2.3%7D 19.0%3M AN US$23.57author fair value 17 Junauthor updated this narrative Urbanization And Digital Adoption Will Transform US Banking
EXEL Exelixis US$53.968.7% overvalued intrinsic discount 2.1%7D 23.0%3M AN US$49.65author fair value 11 Junauthor updated this narrative Expanding Global Oncology Markets Will Broaden Patient Access
CS AXA €43.837.8% undervalued intrinsic discount 1.7%7D 8.2%3M AN €47.51author fair value 18 Junauthor updated this narrative CS: Rising Profit Margins And Multiples Will Drive Global Expansion
COPN Cosmo CHF 68.1032.1% undervalued intrinsic discount 1.6%7D -21.6%3M AN CHF 100.28author fair value 22 Junauthor updated this narrative EMA Hurdles And Generics Will Stall Growth But Enable Recovery
4206 Aica Kogyo Company JP¥3,720.008.1% undervalued intrinsic discount 1.6%7D 1.6%3M JP¥4.05kauthor fair value 25 Julauthor updated this narrative Analysts are neutral with a Price Target of ¥4,050 based on 10.5% annual revenue growth forecasts.
DKSH DKSH Holding CHF 62.8013.5% undervalued intrinsic discount 1.5%7D 7.9%3M AN CHF 72.57author fair value 11 Febauthor updated this narrative Asia Pacific Expansion And Digitalization Will Fuel Sustainable Success
AGS ageas €69.752.6% overvalued intrinsic discount 1.2%7D 7.6%3M AN €67.99author fair value 26 Junauthor updated this narrative Asian Life Shift And Esure Integration Will Drive Stronger, More Resilient Earnings Ahead
MRP Millrose Properties US$29.6623.2% undervalued intrinsic discount 0.9%7D 7.3%3M AN US$38.6author fair value 14 Decauthor updated this narrative Long-Term Housing Undersupply And AI Underwriting Will Support Strong Future Performance
RNST Renasant US$43.664.2% undervalued intrinsic discount 0.9%7D 17.9%3M AN US$45.57author fair value 15 Junauthor updated this narrative Southeastern Expansion And Merger Synergies Will Create Value
MFC Manulife Financial CA$57.523.9% overvalued intrinsic discount 0.8%7D 18.4%3M AN CA$55.38author fair value 22 Junauthor updated this narrative MFC: Sector Headwinds And Mixed Performance Will Shape Near-Term Outlook
HACK Hacksaw SEK 78.3039.7% undervalued intrinsic discount 0.6%7D 27.1%3M AN SEK 129.94author fair value 15 Febauthor updated this narrative Expanding Games Portfolio And OpenRGS Platform Will Support Stronger Long Term Earnings Power
966 China Taiping Insurance Holdings HK$18.8925.1% undervalued intrinsic discount 0.05%7D -10.6%3M HK$25.23author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of HK$25.23 based on 103.3% annual revenue growth forecasts.
BETS B Betsson SEK 85.0549.1% undervalued intrinsic discount -0.4%7D -16.4%3M IM SEK 167author fair value 04 Junauthor updated this narrative The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting
EVO Evolution SEK 671.8035.4% undervalued intrinsic discount -0.5%7D 11.2%3M IM SEK 1.04kauthor fair value 04 Junauthor updated this narrative A Monopoly-Quality Business Trading at Distress Multiples — CEO Buying, €346M Buyback Active, 73% Upside to Fair Value
BS6 Yangzijiang Shipbuilding (Holdings) S$3.4536.8% undervalued intrinsic discount -1.4%7D -9.9%3M KA S$5.46author fair value 04 Junauthor updated this narrative Yangzijiang Shipbuilding Aims for a 30% Profit Margin Boost
AGI Alamos Gold CA$43.0043.1% undervalued intrinsic discount -2.5%7D -32.8%3M AN CA$75.55author fair value 23 Junauthor updated this narrative Analysts Lift Alamos Gold Price Target Amid Strong Growth Improved Margins and Positive Outlook
TPC Tutor Perini US$79.5129.8% undervalued intrinsic discount -3.5%7D 2.9%3M AN US$113.25author fair value 18 Junauthor updated this narrative Record Backlog And Public Projects Will Generate Future Value
EMR Emerald Resources AU$5.3631.9% undervalued intrinsic discount -3.8%7D -5.3%3M AU$7.87author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of A$7.87 based on 57.8% annual revenue growth forecasts.
4042 Tosoh JP¥2,838.008.2% undervalued intrinsic discount -3.9%7D 21.4%3M JP¥3.09kauthor fair value 19 Junauthor updated this narrative Analysts are neutral with a Price Target of ¥3,059 based on 8.5% annual revenue growth forecasts.
939 China Construction Bank HK$7.8420.0% undervalued intrinsic discount -5.5%7D -7.2%3M AN HK$9.8author fair value 17 Junauthor updated this narrative Mounting Headwinds And Digital Shifts Will Suppress Future Margins
LKNC.Y Luckin Coffee US$29.0336.5% undervalued intrinsic discount -8.0%7D -7.0%3M AN US$45.7author fair value 23 Junauthor updated this narrative Chinese Urbanization And Digital Transformation Will Unlock Market Potential

Watching

Company	Price & Valuation	My FV & Narrative	Valuation	Growth	Analyst Target
2419 Dekon Food and Agriculture Group 19.0%7D -29.4%3M	HK$46.82 53.7% undervalued intrinsic discount	HK$101.02author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$101.02 based on 10.0% annual revenue growth forecasts.	PE 10.9x	E 51.4%	HK$101.02
RHM Rheinmetall 10.7%7D -33.1%3M	€1,050.60 44.4% undervalued intrinsic discount	AN €1.89kauthor fair value 15 Junauthor updated this narrative Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall	PE 46.6x	E 30.7%	€1,765.60
ALHC Alignment Healthcare 10.7%7D 28.0%3M	US$24.01 3.7% undervalued intrinsic discount	AN US$24.92author fair value 30 Mayauthor updated this narrative ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains	PS 1.2x	E 39.5%	US$24.92
9911 Newborn Town 8.6%7D -0.5%3M	HK$8.20 41.3% undervalued intrinsic discount	HK$13.97author fair value 25 Julauthor updated this narrative Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.	PE 10.7x	E 16.7%	HK$13.97
NIC Nicolet Bankshares 8.0%7D 13.4%3M	US$168.82 3.1% undervalued intrinsic discount	US$174.2author fair value 25 Julauthor updated this narrative Analysts are neutral with a Price Target of $174.20 based on 27.2% annual revenue growth forecasts.	PE 26.9x	E 40.4%	US$174.20
MNSO MINISO Group Holding 7.3%7D -24.2%3M	US$12.18 40.2% undervalued intrinsic discount	AN US$20.37author fair value 29 Junauthor updated this narrative Global Retail Expansion And Premium IP Will Unlock Opportunity	PE 12.3x	E 20.0%	US$19.87
CCB Coastal Financial 6.6%7D 2.8%3M	US$79.84 24.9% undervalued intrinsic discount	US$106.25author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.	PE 24.7x	E 45.5%	US$106.25
CAMX Camurus 6.1%7D 19.3%3M	SEK 577.00 25.1% undervalued intrinsic discount	AN SEK 770.13author fair value 29 Aprauthor updated this narrative Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery	PE 50.3x	E 34.4%	SEK 769.50
ARGX argenx 6.0%7D 22.6%3M	€793.60 8.7% undervalued intrinsic discount	AN €869.07author fair value 30 Junauthor updated this narrative ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook	PE 37.7x	E 21.4%	€875.21
999 Xiaocaiyuan International Holding 5.5%7D 1.6%3M	HK$6.91 23.6% undervalued intrinsic discount	HK$9.04author fair value 19 Decauthor updated this narrative Analysts are bullish with a Price Target of HK$9.04 based on 3.8% annual revenue growth forecasts.	PE 9.8x	E 6.8%	HK$9.04
MELI MercadoLibre 5.0%7D 1.6%3M	US$1,742.19 21.4% undervalued intrinsic discount	AN US$2.22kauthor fair value 15 Junauthor updated this narrative Digital Retail And MercadoPago Adoption Will Fuel Future Markets	PE 46x	E 26.8%	US$2,208.63
ONC BeOne Medicines 4.9%7D -6.5%3M	US$290.74 29.5% undervalued intrinsic discount	AN US$412.35author fair value 24 Junauthor updated this narrative ONC: Pivotal Oncology Trial Data Will Drive Future Upside Momentum	PE 63x	E 29.2%	US$412.38
BAER Julius Bär Gruppe 4.9%7D 20.3%3M	CHF 71.84 3.6% overvalued intrinsic discount	AN CHF 69.35author fair value 18 Junauthor updated this narrative Digital Transformation And Global Wealth Transfers Will Empower Private Banking	PE 19.3x	E 13.4%	CHF 69.71
BDT Bird Construction 4.6%7D 57.0%3M	CA$64.73 74.9% overvalued intrinsic discount	AN CA$37author fair value 28 Marauthor updated this narrative Defense And Data Center Backlog Will Support Stable Long Term Earnings Profile	PE 72.6x	E 49.2%	CA$63.38
FITB Fifth Third Bancorp 4.6%7D 22.0%3M	US$57.49 1.2% undervalued intrinsic discount	AN US$58.18author fair value 25 Junauthor updated this narrative Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts	PE 25.7x	E 22.4%	US$58.38
8795 T&D Holdings 4.6%7D 18.1%3M	JP¥4,904.00 8.9% overvalued intrinsic discount	AN JP¥4.51kauthor fair value 02 Mayauthor updated this narrative Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins	PE 16.9x	E 6.1%	JP¥4,954.00
HRMY Harmony Biosciences Holdings 4.5%7D 29.8%3M	US$36.00 23.9% undervalued intrinsic discount	AN US$47.3author fair value 23 Febauthor updated this narrative Expanding Sleep And Rare Disease Markets Will Unlock Future Potential	PE 14.3x	E 19.3%	US$44.91
MLYS Mineralys Therapeutics 4.3%7D -0.3%3M	US$26.89 47.1% undervalued intrinsic discount	AN US$50.88author fair value 05 Marauthor updated this narrative Hypertension And Cardiorenal Catalysts Will Reshape Long Term Prospects For This Biotech	PB 3.7x	E 56.8%	US$49.00
MRK Merck 4.0%7D 3.7%3M	US$125.37 3.4% undervalued intrinsic discount	AN US$129.74author fair value 01 Junauthor updated this narrative US Investments And New Product Launches Will Shape Future Markets	PE 34.7x	E 19.4%	US$130.78
MONY MONY Group 3.9%7D 26.2%3M	UK£1.90 32.1% undervalued intrinsic discount	AN UK£2.8author fair value 04 Junauthor updated this narrative Rising Middle Class And AI Integration Will Expand Markets	PE 12.1x	E 7.0%	UK£2.28
PNFP Pinnacle Financial Partners 3.9%7D 15.3%3M	US$100.82 13.7% undervalued intrinsic discount	AN US$116.79author fair value 05 Junauthor updated this narrative PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside	PE 24.2x	E 41.3%	US$118.10
RUSTA Rusta 3.4%7D -13.3%3M	SEK 81.40 8.9% undervalued intrinsic discount	AN SEK 89.33author fair value 22 Junauthor updated this narrative Upcoming Store Expansion And Supply Chain Investments Will Increase Future Market Reach	PE 22.7x	E 14.7%	SEK 89.33
COLB Columbia Banking System 3.1%7D 17.2%3M	US$32.51 0.9% overvalued intrinsic discount	AN US$32.23author fair value 24 Junauthor updated this narrative COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance	PE 14.4x	E 14.4%	US$32.69
HBAN Huntington Bancshares 3.0%7D 14.7%3M	US$18.11 79.1% overvalued intrinsic discount	MS US$10.11author fair value 27 Sepauthor updated this narrative Overvalued HBAN	PE 17.7x	E 16.4%	US$20.12
ADS adidas 3.0%7D 35.8%3M	€183.20 8.3% undervalued intrinsic discount	AN €199.71author fair value 18 Junauthor updated this narrative ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny	PE 23.3x	E 15.2%	€205.76
AU AngloGold Ashanti 2.9%7D -20.1%3M	US$80.89 34.4% undervalued intrinsic discount	AN US$123.29author fair value 28 Mayauthor updated this narrative AU: Strengthening Margins And Revenue Will Drive Upward Momentum In Coming Years	PE 11.8x	E 10.9%	US$118.38
SFNC Simmons First National 2.3%7D 19.0%3M	US$23.22 1.5% undervalued intrinsic discount	AN US$23.57author fair value 17 Junauthor updated this narrative Urbanization And Digital Adoption Will Transform US Banking	PB 1x	E 112.8%	US$23.71
EXEL Exelixis 2.1%7D 23.0%3M	US$53.96 8.7% overvalued intrinsic discount	AN US$49.65author fair value 11 Junauthor updated this narrative Expanding Global Oncology Markets Will Broaden Patient Access	PE 16.3x	E 10.4%	US$49.50
CS AXA 1.7%7D 8.2%3M	€43.83 7.8% undervalued intrinsic discount	AN €47.51author fair value 18 Junauthor updated this narrative CS: Rising Profit Margins And Multiples Will Drive Global Expansion	PE 12.4x	E 6.7%	€47.62
COPN Cosmo 1.6%7D -21.6%3M	CHF 68.10 32.1% undervalued intrinsic discount	AN CHF 100.28author fair value 22 Junauthor updated this narrative EMA Hurdles And Generics Will Stall Growth But Enable Recovery	PS 11.5x	E 42.0%	CHF 128.38
4206 Aica Kogyo Company 1.6%7D 1.6%3M	JP¥3,720.00 8.1% undervalued intrinsic discount	JP¥4.05kauthor fair value 25 Julauthor updated this narrative Analysts are neutral with a Price Target of ¥4,050 based on 10.5% annual revenue growth forecasts.	PE 12.7x	E 5.1%	JP¥4,050.00
DKSH DKSH Holding 1.5%7D 7.9%3M	CHF 62.80 13.5% undervalued intrinsic discount	AN CHF 72.57author fair value 11 Febauthor updated this narrative Asia Pacific Expansion And Digitalization Will Fuel Sustainable Success	PE 20.1x	E 9.2%	CHF 74.31
AGS ageas 1.2%7D 7.6%3M	€69.75 2.6% overvalued intrinsic discount	AN €67.99author fair value 26 Junauthor updated this narrative Asian Life Shift And Esure Integration Will Drive Stronger, More Resilient Earnings Ahead	PE 7.8x	E 2.5%	€67.99
MRP Millrose Properties 0.9%7D 7.3%3M	US$29.66 23.2% undervalued intrinsic discount	AN US$38.6author fair value 14 Decauthor updated this narrative Long-Term Housing Undersupply And AI Underwriting Will Support Strong Future Performance	PE 10.6x	E 5.5%	US$37.60
RNST Renasant 0.9%7D 17.9%3M	US$43.66 4.2% undervalued intrinsic discount	AN US$45.57author fair value 15 Junauthor updated this narrative Southeastern Expansion And Merger Synergies Will Create Value	PE 17.7x	E 22.6%	US$45.57
MFC Manulife Financial 0.8%7D 18.4%3M	CA$57.52 3.9% overvalued intrinsic discount	AN CA$55.38author fair value 22 Junauthor updated this narrative MFC: Sector Headwinds And Mixed Performance Will Shape Near-Term Outlook	PE 16.2x	E 10.1%	CA$55.38
HACK Hacksaw 0.6%7D 27.1%3M	SEK 78.30 39.7% undervalued intrinsic discount	AN SEK 129.94author fair value 15 Febauthor updated this narrative Expanding Games Portfolio And OpenRGS Platform Will Support Stronger Long Term Earnings Power	PE 13.2x	E 24.8%	SEK 103.49
966 China Taiping Insurance Holdings 0.05%7D -10.6%3M	HK$18.89 25.1% undervalued intrinsic discount	HK$25.23author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of HK$25.23 based on 103.3% annual revenue growth forecasts.	PE 2.6x	E -17.3%	HK$25.23
BETS B Betsson -0.4%7D -16.4%3M	SEK 85.05 49.1% undervalued intrinsic discount	IM SEK 167author fair value 04 Junauthor updated this narrative The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting	PE 6.7x	E 0.7%	SEK 96.67
EVO Evolution -0.5%7D 11.2%3M	SEK 671.80 35.4% undervalued intrinsic discount	IM SEK 1.04kauthor fair value 04 Junauthor updated this narrative A Monopoly-Quality Business Trading at Distress Multiples — CEO Buying, €346M Buyback Active, 73% Upside to Fair Value	PE 11.2x	E 4.3%	SEK 680.80
BS6 Yangzijiang Shipbuilding (Holdings) -1.4%7D -9.9%3M	S$3.45 36.8% undervalued intrinsic discount	KA S$5.46author fair value 04 Junauthor updated this narrative Yangzijiang Shipbuilding Aims for a 30% Profit Margin Boost	PE 8.3x	E 9.4%	S$4.46
AGI Alamos Gold -2.5%7D -32.8%3M	CA$43.00 43.1% undervalued intrinsic discount	AN CA$75.55author fair value 23 Junauthor updated this narrative Analysts Lift Alamos Gold Price Target Amid Strong Growth Improved Margins and Positive Outlook	PE 12x	E 15.8%	CA$73.75
TPC Tutor Perini -3.5%7D 2.9%3M	US$79.51 29.8% undervalued intrinsic discount	AN US$113.25author fair value 18 Junauthor updated this narrative Record Backlog And Public Projects Will Generate Future Value	PE 53.5x	E 49.6%	US$113.25
EMR Emerald Resources -3.8%7D -5.3%3M	AU$5.36 31.9% undervalued intrinsic discount	AU$7.87author fair value 19 Junauthor updated this narrative Analysts are bullish with a Price Target of A$7.87 based on 57.8% annual revenue growth forecasts.	PE 35x	E 48.1%	AU$7.87
4042 Tosoh -3.9%7D 21.4%3M	JP¥2,838.00 8.2% undervalued intrinsic discount	JP¥3.09kauthor fair value 19 Junauthor updated this narrative Analysts are neutral with a Price Target of ¥3,059 based on 8.5% annual revenue growth forecasts.	PE 21x	E 11.9%	JP¥3,092.22
939 China Construction Bank -5.5%7D -7.2%3M	HK$7.84 20.0% undervalued intrinsic discount	AN HK$9.8author fair value 17 Junauthor updated this narrative Mounting Headwinds And Digital Shifts Will Suppress Future Margins	PE 5.3x	E 5.4%	HK$10.73
LKNC.Y Luckin Coffee -8.0%7D -7.0%3M	US$29.03 36.5% undervalued intrinsic discount	AN US$45.7author fair value 23 Junauthor updated this narrative Chinese Urbanization And Digital Transformation Will Unlock Market Potential	PE 17.8x	E 22.3%	US$45.52

Beat the Benchmark 2026 Portfolio - Possible list

Watching

Analysts are bullish with a Price Target of HK$101.02 based on 10.0% annual revenue growth forecasts.

Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall

ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains

Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.

Analysts are neutral with a Price Target of $174.20 based on 27.2% annual revenue growth forecasts.

Global Retail Expansion And Premium IP Will Unlock Opportunity

Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.

Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery

ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook

Analysts are bullish with a Price Target of HK$9.04 based on 3.8% annual revenue growth forecasts.

Digital Retail And MercadoPago Adoption Will Fuel Future Markets

ONC: Pivotal Oncology Trial Data Will Drive Future Upside Momentum

Digital Transformation And Global Wealth Transfers Will Empower Private Banking

Defense And Data Center Backlog Will Support Stable Long Term Earnings Profile

Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts

Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins

Expanding Sleep And Rare Disease Markets Will Unlock Future Potential

Hypertension And Cardiorenal Catalysts Will Reshape Long Term Prospects For This Biotech

US Investments And New Product Launches Will Shape Future Markets

Rising Middle Class And AI Integration Will Expand Markets

PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside

Upcoming Store Expansion And Supply Chain Investments Will Increase Future Market Reach

COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance

Overvalued HBAN

ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny

AU: Strengthening Margins And Revenue Will Drive Upward Momentum In Coming Years

Urbanization And Digital Adoption Will Transform US Banking

Expanding Global Oncology Markets Will Broaden Patient Access

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

EMA Hurdles And Generics Will Stall Growth But Enable Recovery

Analysts are neutral with a Price Target of ¥4,050 based on 10.5% annual revenue growth forecasts.

Asia Pacific Expansion And Digitalization Will Fuel Sustainable Success

Asian Life Shift And Esure Integration Will Drive Stronger, More Resilient Earnings Ahead

Long-Term Housing Undersupply And AI Underwriting Will Support Strong Future Performance

Southeastern Expansion And Merger Synergies Will Create Value

MFC: Sector Headwinds And Mixed Performance Will Shape Near-Term Outlook

Expanding Games Portfolio And OpenRGS Platform Will Support Stronger Long Term Earnings Power

Analysts are bullish with a Price Target of HK$25.23 based on 103.3% annual revenue growth forecasts.

The Market Is Paying You a 9.3% Dividend and an 18.9% FCF Yield to Wait for a Recovery That's Already Starting

A Monopoly-Quality Business Trading at Distress Multiples — CEO Buying, €346M Buyback Active, 73% Upside to Fair Value

Yangzijiang Shipbuilding Aims for a 30% Profit Margin Boost

Analysts Lift Alamos Gold Price Target Amid Strong Growth Improved Margins and Positive Outlook

Record Backlog And Public Projects Will Generate Future Value

Analysts are bullish with a Price Target of A$7.87 based on 57.8% annual revenue growth forecasts.

Analysts are neutral with a Price Target of ¥3,059 based on 8.5% annual revenue growth forecasts.

Mounting Headwinds And Digital Shifts Will Suppress Future Margins

Chinese Urbanization And Digital Transformation Will Unlock Market Potential

Watching

Analysts are bullish with a Price Target of HK$101.02 based on 10.0% annual revenue growth forecasts.

Analysts Highlight Cautious Optimism Amid Valuation Gains and Strategic Shifts at Rheinmetall

ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains

Analysts are bullish with a Price Target of HK$13.97 based on 24.4% annual revenue growth forecasts.

Analysts are neutral with a Price Target of $174.20 based on 27.2% annual revenue growth forecasts.

Global Retail Expansion And Premium IP Will Unlock Opportunity

Analysts are bullish with a Price Target of $106.25 based on 77.0% annual revenue growth forecasts.

Global Expansion And Regulatory Approvals Will Transform Healthcare Delivery

ARGX: Upcoming Phase 3 Readouts and Expanded Access Will Shape Future Outlook

Analysts are bullish with a Price Target of HK$9.04 based on 3.8% annual revenue growth forecasts.

Digital Retail And MercadoPago Adoption Will Fuel Future Markets

ONC: Pivotal Oncology Trial Data Will Drive Future Upside Momentum

Digital Transformation And Global Wealth Transfers Will Empower Private Banking

Defense And Data Center Backlog Will Support Stable Long Term Earnings Profile

Analyst Commentary Highlights Optimism and Caution on Fifth Third Bancorp Amid Merger and Valuation Shifts

Analysts Lift T&D Holdings Price Target as Revenue Outlook Improves Despite Lower Margins

Expanding Sleep And Rare Disease Markets Will Unlock Future Potential

Hypertension And Cardiorenal Catalysts Will Reshape Long Term Prospects For This Biotech

US Investments And New Product Launches Will Shape Future Markets

Rising Middle Class And AI Integration Will Expand Markets

PNFP: Revenue Momentum And Pending Synovus Merger Will Drive Future Upside

Upcoming Store Expansion And Supply Chain Investments Will Increase Future Market Reach

COLB: Upgraded Ratings And Peer-Leading Returns Will Drive Outperformance

Overvalued HBAN

ADS: Stable Profit Margins Will Support Renewed Confidence Amid Legal Scrutiny

AU: Strengthening Margins And Revenue Will Drive Upward Momentum In Coming Years

Urbanization And Digital Adoption Will Transform US Banking

Expanding Global Oncology Markets Will Broaden Patient Access

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

EMA Hurdles And Generics Will Stall Growth But Enable Recovery